Tech Company Financing Transactions
ImaginAb Funding Round
ImaginAb, operating out of Inglewood, scored $21 million from Merieux Developpement, Cycad Group and Nextech Invest.
Transaction Overview
Company Name
Announced On
5/9/2014
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series B
Investors
Merieux Developpement (Lead Investor) (Valerie Calenda)
Cycad Group (Leonard Judson)
Proceeds Purpose
We have made excellent progress with our programs in cancer and immunology, and we are pleased to have concluded this round of growth capital to accelerate the development of IAB2M, our lead program in prostate cancer, and continue to expand our product pipeline.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
423 Hindry Ave. D
Inglewood, CA 90301
USA
Inglewood, CA 90301
USA
Phone
Website
Email Address
Overview
ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ian Wilson
Chief Financial Officer
David Fractor
VP - Bus. Development
William Le
VP - Bus. Development
Ivan Plavec
Browse more venture capital transactions:
Prev: 5/8/2014: ViziApps venture capital transaction
Next: 5/9/2014: BuildDirect Technologies venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs